Nanotechnology for microglial targeting and inhibition of neuroinflammation underlying Alzheimer's pathology.

Hoda M GebrilAravind AryasomayajulaMariana Reis Nogueira de LimaKathryn E UhrichPrabhas V Moghe

Published in: Translational neurodegeneration (2024)

The AM-NP nanotechnology presents a multifactorial strategy to target pathological Aβ aggregation and arrest the fAβ-mediated pathological progression in microglia and neurons.

Keyphrases

inflammatory response
lipopolysaccharide induced
lps induced
neuropathic pain
spinal cord
traumatic brain injury
cognitive decline
cancer therapy
cell cycle
cognitive impairment
spinal cord injury
cerebral ischemia
blood brain barrier